220 related articles for article (PubMed ID: 36185045)
1. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis.
Ouyang ZQ; Zheng GR; Duan XR; Zhang XR; Ke TF; Bao SS; Yang J; He B; Liao CD
Quant Imaging Med Surg; 2023 Aug; 13(8):4943-4959. PubMed ID: 37581048
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of perfusion MRI value for tumor progression assessment after glioma radiotherapy: A systematic review and meta-analysis.
Wang L; Wei L; Wang J; Li N; Gao Y; Ma H; Qu X; Zhang M
Medicine (Baltimore); 2020 Dec; 99(52):e23766. PubMed ID: 33350761
[TBL] [Abstract][Full Text] [Related]
4. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
Qiu J; Tao ZC; Deng KX; Wang P; Chen CY; Xiao F; Luo Y; Yuan SY; Chen H; Huang H
Chin Med J (Engl); 2021 Oct; 134(21):2535-2543. PubMed ID: 34748524
[TBL] [Abstract][Full Text] [Related]
6. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
7. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiation Between Recurrence and Pseudoprogression in High-Grade Glioma: A Meta-analysis.
Gu X; He X; Wang H; Li J; Chen R; Liu H
J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):303-310. PubMed ID: 37654056
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.
Wan B; Wang S; Tu M; Wu B; Han P; Xu H
Medicine (Baltimore); 2017 Mar; 96(11):e6333. PubMed ID: 28296759
[TBL] [Abstract][Full Text] [Related]
11. Differentiation Between True Tumor Progression of Glioblastoma and Pseudoprogression Using Diffusion-Weighted Imaging and Perfusion-Weighted Imaging: Systematic Review and Meta-analysis.
Tsakiris C; Siempis T; Alexiou GA; Zikou A; Sioka C; Voulgaris S; Argyropoulou MI
World Neurosurg; 2020 Dec; 144():e100-e109. PubMed ID: 32777397
[TBL] [Abstract][Full Text] [Related]
12. MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.
Patel P; Baradaran H; Delgado D; Askin G; Christos P; John Tsiouris A; Gupta A
Neuro Oncol; 2017 Jan; 19(1):118-127. PubMed ID: 27502247
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
14. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
[TBL] [Abstract][Full Text] [Related]
16. Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis.
Taylor C; Ekert JO; Sefcikova V; Fersht N; Samandouras G
Sci Rep; 2022 Aug; 12(1):13258. PubMed ID: 35918373
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
[TBL] [Abstract][Full Text] [Related]
19. Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression.
Shi W; Qu C; Wang X; Liang X; Tan Y; Zhang H
Eur J Radiol; 2021 Nov; 144():109941. PubMed ID: 34735828
[TBL] [Abstract][Full Text] [Related]
20. The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
Xu W; Wang Q; Shao A; Xu B; Zhang J
PLoS One; 2017; 12(3):e0173430. PubMed ID: 28301491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
